Neurogene (NGNE) traded down -3.01 % during a 24 hours period ending at 03:11 PM Central Europe on Monday 26th. One Neurogene stock can currently be bought for about USD 23.68 on popular exchanges. Current supply of Neurogene stocks is 20 mn. Neurogene has a current market capitalization of USD 471.3 mn and approximately USD 2.9 mn worth of Neurogene was traded on exchanges in the last 24 hours. Since last month end, Neurogene has traded -24.64 % down. Simple moving average of last 200 days is at USD 27.58. The highest price of past 52 weeks was recorded at USD 43.66 on 07/09/2026. 52 weeks low was at USD 15.93 on 02/05/2026.
Here is how related stocks have performed in the past 24 hours:
Park Aerospace (PKE) traded up 0.47 % and now trades at USD 25.9. Current market capitalisation for Park Aerospace is USD 559 mn. Current price/earnings ratio for Park Aerospace is 35.84.
Carriage Services (CSV) traded down -4.25 % and now trades at USD 35.99. Current market capitalisation for Carriage Services is USD 562.4 mn. Carriage Services has a current price to earnings ratio of 12.95.
Prokidney (PROK) traded down -1.4 % and now trades at USD 1.4. Current market capitalisation for Prokidney is USD 562.8 mn.
Olema (OLMA) traded down -8.69 % and now trades at USD 6.47. Olema has a market capitalisation of USD 560.9 mn.
Myriad Genetics (MYGN) traded up 1.04 % and now trades at USD 5.91. Current market capitalisation for Myriad Genetics is USD 556.7 mn.
About Neurogene
Neurogene Inc. is a biopharmaceutical company that specializes in developing genetic medicines for individuals and their families affected by severe neurological diseases. Based in New York, United States, the company serves customers globally through its website at www.neurogene.com and trades on the Nasdaq stock exchange. The IPO of the company took place on March 7, 2014.
